Source: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2024 Aug 02; Vol. 24 (1), pp. 219. Date of Electronic Publication: 2024 Aug 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101088682 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6947

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey.

Authors : Oguchi Y; Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.; Miyake N

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/administration & dosage ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Delayed-Action Preparations*

Source: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Jun; Vol. 44 (2), pp. 417-423. Date of Electronic Publication: 2024 Apr 18.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101719700 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Novel Atypical Antipsychotic Lurasidone Affects Cytochrome P450 Expression in the Liver and Peripheral Blood Lymphocytes.

Authors : Danek PJ; Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.; Daniel WA

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/metabolism; Humans

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 27; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride.

Authors : Rocchetti J; Department of Psychiatry, Douglas Hospital, Mc Gill University, Montreal, Québec, Canada.; Fasano C

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Animals

Source: PloS one [PLoS One] 2023 Aug 25; Vol. 18 (8), pp. e0289770. Date of Electronic Publication: 2023 Aug 25 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition.

Authors : Ecevitoglu A; Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA.; Edelstein GA

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Rats

Source: Psychopharmacology [Psychopharmacology (Berl)] 2023 Aug; Vol. 240 (8), pp. 1747-1757. Date of Electronic Publication: 2023 Jun 26.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Global trends in antidepressant, atypical antipsychotic, and benzodiazepine use: A cross-sectional analysis of 64 countries.

Authors : Alabaku O; University of Pittsburgh, Pittsburgh, PA, United States of America.; Yang A

Subjects: Benzodiazepines*/Benzodiazepines*/Benzodiazepines*/therapeutic use ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Cross-Sectional Studies

Source: PloS one [PLoS One] 2023 Apr 26; Vol. 18 (4), pp. e0284389. Date of Electronic Publication: 2023 Apr 26 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone.

Authors : Støve SI; Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009, Bergen, Norway. .; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway. .

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology; Animals ; Rats

Source: Communications biology [Commun Biol] 2022 Nov 23; Vol. 5 (1), pp. 1283. Date of Electronic Publication: 2022 Nov 23.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.

Authors : Danek PJ; Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.; Daniel WA

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/metabolism

Source: Cells [Cells] 2022 Nov 06; Vol. 11 (21). Date of Electronic Publication: 2022 Nov 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.

Authors : Danek PJ; Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.; Daniel WA

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*pharmacology ; Cytochrome P-450 Enzyme System/Cytochrome P-450 Enzyme System/Cytochrome P-450 Enzyme System/*genetics ; Isoxazoles/Isoxazoles/Isoxazoles/*pharmacology

Source: Cells [Cells] 2021 Dec 09; Vol. 10 (12). Date of Electronic Publication: 2021 Dec 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial.

Authors : Liu C; National Clinical Research Center for Mental Disorders, and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.; Kang D

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Probiotics*/Probiotics*/Probiotics*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis

Source: Trials [Trials] 2021 Feb 23; Vol. 22 (1), pp. 159. Date of Electronic Publication: 2021 Feb 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania.

Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey.

The Novel Atypical Antipsychotic Lurasidone Affects Cytochrome P450 Expression in the Liver and Peripheral Blood Lymphocytes.

Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride.

Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition.

Global trends in antidepressant, atypical antipsychotic, and benzodiazepine use: A cross-sectional analysis of 64 countries.

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone.

The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.

Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial.

اتصل بنا

اتبع